DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Semeraro F, Incampo F, Ammollo CT. et al.
Dabigatran but not rivaroxaban or apixaban treatment decreases fibrinolytic resistance in patients with atrial fibrillation.
Thromb Res 2016;
138: 22-29.
We do not assume any responsibility for the contents of the web pages of other providers.